Project title: New strategies to improve drug development for carcinoid tumors

Emily Bergsland, MD University of California, San Francisco

Emily Bergsland, MD
  • Status: Active
  • Year(s): 2018
  • Grant Type: Investigator
  • Research Type: Clinical
  • Primary Tumor Site: Small intestine
  • Area of Inquiry: Clinical trials

General Description

Incorporating serial blood samples and CT scan images from a recently clinical trial, a team of investigators from around the country will explore new approaches to monitoring response: evaluation of multiple proteins in circulating blood, and computational analysis of CT images. This very novel work could lead to the identification of better ways of assessing treatment effects, facilitating testing of the next generation of therapeutic agents in NETs.

Additional Details

  • City: San Francisco
  • State: California
  • Grant Duration: 2 years


NETRF funds laboratory research to understand the development of neuroendocrine tumors and translational research to explore new concepts in treatment. Research grant descriptions and research updates from NETRF are not intended to serve as medical advice. It can take years for research discoveries to be fully validated and approved for patient care. Always consult your health care providers about your treatment options.

« Back to all funded research projects